Tenon Medical, a medical device company focused on sacro-pelvic disorders, has entered a private placement agreement to sell 597,610 shares and warrants for up to 1,058,517 shares at an effective price of about $5.02 each. The deal, arranged by WallachBeth Capital, is expected to raise approximately $3 million before fees and close around August 31, 2026. This funding will support Tenon's ongoing development and operations. The securities are offered under exemptions from registration and include customary registration rights for future resale.
Affirm Holdings reported quarterly results that exceeded expectations, boosting its shares by nearly 10% in after-hours trading. The company showed strong business resilience with low delinquency rates and 36% growth in gross merchandise volume, desp...
Purepoint Uranium Group Inc completed a non-brokered private placement, raising approximately $1.01 million by issuing 2.65 million flow-through units at $0.38 each. Each unit includes one flow-through common share and a warrant exercisable at $0.50 ...
Meta shares have dropped over 23% in the past year, pressured by a Q2 earnings miss despite strong revenue growth. The company’s AI investments are driving ad revenue gains, with ad impressions up 14% and average ad prices rising 12%. A proprietary m...
Robinhood remains a Buy with technical indicators suggesting a possible breakout above $115, supported by a diverse platform covering trading, retirement, banking, and crypto. The stock has risen 61.5% since the last analysis, and the evolving multi-...
The New York Stock Exchange (NYSE) provided a pre-market update focusing on key market developments, including Fireblocks' report that nearly 90% of banks are investing in digital asset infrastructure. Precidian Investments aims to lead innovation wi...
